Evidence from epidemiological, clinical, and neuropathology has shown that patients with diabetes are at higher risk of developing AD due to impaired brain insulin signaling (Barbiellini Amidei et al., 2021; De Felice et al., 2022). Here, INS is linked to diabetes mellitus.